JAKARTA – PT Ferron Par Pharmaceuticals, part of Dexa Group, has reinforced its commitment to supporting cancer treatment and anesthesia services in Indonesia by donating over 3,000 units of oncology, anesthesia, antihistamine, antithrombotic, and antibiotic medicines to three referral hospitals located in Tangerang, Solo, and Medan.
This initiative is part of Dharma Dexa, the Corporate Social Initiative of Dexa Group, and is expected to benefit thousands of patients throughout 2025 while enhancing access to quality healthcare services across various regions in Indonesia.
“This donation reflects our tangible commitment to realizing Dexa Group’s core value of Expertise for the Promotion of Health. We aim to ensure that the essential and urgently needed medicines are available for patients at these hospitals,” stated Mr. Benny Sutisna Suwarno, President Director of PT Ferron Par Pharmaceuticals, in a written statement on Friday (April 25, 2025).
Mr. Benny further emphasized Ferron’s long-term commitment to supporting cancer treatment in Indonesia, in line with the vision of Dexa Group’s Founder, Lt. Col. (Ret.) Drs. Rudy Soetikno, Apt.
This donation not only delivers direct benefits to patients and hospitals but also strengthens the national pharmaceutical industry by increasing local content (TKDN) and optimizing the Corporate Benefit Weight (BMP). Ferron consistently innovates in the development of locally manufactured products and ensures the availability of essential medicines for the Indonesian community.
“This initiative is also part of the company’s strategy to enhance our BMP score, which will positively impact all Ferron products listed in the national e-catalogue, and aligns with our efforts to increase TKDN from 13.26% to a targeted 15%,” explained Mr. Johannes Suthya, Commercial Director of PT Ferron Par Pharmaceuticals.
Meanwhile, Mr. Matheus Ramidi, Manager of Dharma Dexa, stated that this donation program is part of Dharma Dexa’s efforts to deliver sustainable and meaningful health improvements for the Indonesian population through collaboration, innovation, and the strengthening of the national healthcare ecosystem.
Medicines Donated to Three Referral Hospitals
The donations were distributed to three hospitals: RSUP dr. Sitanala Tangerang, RSUD Dr. Moewardi Surakarta, and RSUP H. Adam Malik Medan, North Sumatra.
On Wednesday, April 16, 2025, Ferron Par Pharmaceuticals delivered donations to RSUP dr. Sitanala, Tangerang, including much-needed antihistamines, antithrombotics, antibiotics, and local anesthesia products. RSUP dr. Sitanala was selected due to its high demand for anesthesia products to improve healthcare services. The donation consisted of 360 tablets of Antihistamines, 755 tablets of Antithrombotics, 900 tablets of Antibiotics, and 190 units of Local Anesthesia.
Oncology medicines were donated to RSUD Dr. Moewardi Surakarta and RSUP H. Adam Malik Medan.
Ferron Par Pharmaceuticals donated 300 vials of cytostatic drug Paclitaxel 300 ml to RSUD Dr. Moewardi, a key cancer referral center in Central Java. The donation was handed over by Mr. Rudi Wijayanto, Sales Manager for Central Java at PT Ferron, to Mr. Nandika W. Candra, SE., Akt., Head of the Grant Team at RSUD Dr. Moewardi.
Mr. Nandika expressed appreciation for Ferron’s support, saying,
“We warmly welcome this collaboration and donation. Medicines like Paclitaxel are essential for cancer treatment, and this support will greatly help the community in accessing quality healthcare,” he stated on Monday, April 21, 2025.
Further oncology medicine donations were made to RSUP H. Adam Malik Medan, including 300 vials of Fonkopac and 200 vials of Paclitaxel produced by PT Fonko International Pharmaceuticals. These products have a TKDN of over 25% and are available in the government’s electronic catalogue.
The donation was handed over by Mr. Arif Rakhman, National Sales Manager Oncology at PT Ferron Par Pharmaceuticals, to Ms. Dra. Nurminda Silalahi, M.Si., Apt., Head of Pharmacy Installation at RSUP H. Adam Malik, on Tuesday, April 22, 2025. Dr. Zainal Safri, MKed(PD) SpPD-KKV SpJP(K), President Director of RSUP H. Adam Malik, stated that the donation is highly beneficial, especially as the hospital is preparing to establish an Integrated Oncology Center.
Ms. Nurminda further explained that oncology medicines are urgently needed, especially for patients under Indonesia’s national health insurance program, BPJS Kesehatan. “The demand is high, with approximately 200 patients requiring these medicines each month,” she noted.